auroushealthcare.wordpress.com
SEC recommends waiver of local phase III and IV trials for Sanofi’s orphan drug to treat Pompe disease
The Subject Expert Committee (SEC) that advises the drug regulator of the country has recommended waiver of local phase III and IV clinical trials in India for Sanofi Healthcare India’s orpha…
